Recombinant interferon drug targeting conservative HIV gp41 subunit membrane-proximal ectodomain and application thereof

The invention discloses a recombinant interferon drug targeting a conservative HIV (human immunodeficiency virus) gp41 subunit membrane-proximal ectodomain and application of the recombinant interferon drug. Comprising a 10E8 antibody or an antigen binding fragment thereof and a consensus interferon...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JIAO CHANGLE, HU JIAQI, YUAN SHENGLING, DAI JINGJING, GUAN TONGTONG, HU XIANWEN, WEI YUANYUAN, ZUO MENG, LIU ZILONG, YUAN JIANJUN, ZHANG LIFANG, LIAO XIANG, LI LEI
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator JIAO CHANGLE
HU JIAQI
YUAN SHENGLING
DAI JINGJING
GUAN TONGTONG
HU XIANWEN
WEI YUANYUAN
ZUO MENG
LIU ZILONG
YUAN JIANJUN
ZHANG LIFANG
LIAO XIANG
LI LEI
description The invention discloses a recombinant interferon drug targeting a conservative HIV (human immunodeficiency virus) gp41 subunit membrane-proximal ectodomain and application of the recombinant interferon drug. Comprising a 10E8 antibody or an antigen binding fragment thereof and a consensus interferon alpha, and the 10E8 antibody or the antigen binding fragment thereof is connected with the consensus interferon alpha through a linker. The antibody 10E8 capable of recognizing a highly conservative gp41 subunit MPER region of HIV outer membrane glycoprotein is used as a directional tool of the integrated interferon, a target spot exposed by an outer membrane protein allosteric structure of a virus in an infected cell can be accurately recognized, virus infection is prevented, a neutralization effect is achieved, and meanwhile, the antibody 10E8 can be used for identifying the high conservative gp41 subunit MPER region of the HIV outer membrane glycoprotein. The carried interferon molecules can be more effectively
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN117430716A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN117430716A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN117430716A3</originalsourceid><addsrcrecordid>eNqNjLEOgjAQQFkcjPoP5weQ2EBkNkSDi4MxruQoR21Cr017ED5fBj_A6S3vvW22PEl711lGFrAsFAeKnqGPkwHBaEgsG9CeE8UZxc4Ezf0NJpQK0tRNbAUcuS4iUx6iX6zDEUiL771Dy4DcA4YwWr3W61k-FMkP-2wz4Jjo8OMuO96ur7rJKfiWUkBNTNLWD6WqsjhV6nwp_nG-J_lG_Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Recombinant interferon drug targeting conservative HIV gp41 subunit membrane-proximal ectodomain and application thereof</title><source>esp@cenet</source><creator>JIAO CHANGLE ; HU JIAQI ; YUAN SHENGLING ; DAI JINGJING ; GUAN TONGTONG ; HU XIANWEN ; WEI YUANYUAN ; ZUO MENG ; LIU ZILONG ; YUAN JIANJUN ; ZHANG LIFANG ; LIAO XIANG ; LI LEI</creator><creatorcontrib>JIAO CHANGLE ; HU JIAQI ; YUAN SHENGLING ; DAI JINGJING ; GUAN TONGTONG ; HU XIANWEN ; WEI YUANYUAN ; ZUO MENG ; LIU ZILONG ; YUAN JIANJUN ; ZHANG LIFANG ; LIAO XIANG ; LI LEI</creatorcontrib><description>The invention discloses a recombinant interferon drug targeting a conservative HIV (human immunodeficiency virus) gp41 subunit membrane-proximal ectodomain and application of the recombinant interferon drug. Comprising a 10E8 antibody or an antigen binding fragment thereof and a consensus interferon alpha, and the 10E8 antibody or the antigen binding fragment thereof is connected with the consensus interferon alpha through a linker. The antibody 10E8 capable of recognizing a highly conservative gp41 subunit MPER region of HIV outer membrane glycoprotein is used as a directional tool of the integrated interferon, a target spot exposed by an outer membrane protein allosteric structure of a virus in an infected cell can be accurately recognized, virus infection is prevented, a neutralization effect is achieved, and meanwhile, the antibody 10E8 can be used for identifying the high conservative gp41 subunit MPER region of the HIV outer membrane glycoprotein. The carried interferon molecules can be more effectively</description><language>chi ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; TESTING ; VINEGAR ; WINE</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240123&amp;DB=EPODOC&amp;CC=CN&amp;NR=117430716A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240123&amp;DB=EPODOC&amp;CC=CN&amp;NR=117430716A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JIAO CHANGLE</creatorcontrib><creatorcontrib>HU JIAQI</creatorcontrib><creatorcontrib>YUAN SHENGLING</creatorcontrib><creatorcontrib>DAI JINGJING</creatorcontrib><creatorcontrib>GUAN TONGTONG</creatorcontrib><creatorcontrib>HU XIANWEN</creatorcontrib><creatorcontrib>WEI YUANYUAN</creatorcontrib><creatorcontrib>ZUO MENG</creatorcontrib><creatorcontrib>LIU ZILONG</creatorcontrib><creatorcontrib>YUAN JIANJUN</creatorcontrib><creatorcontrib>ZHANG LIFANG</creatorcontrib><creatorcontrib>LIAO XIANG</creatorcontrib><creatorcontrib>LI LEI</creatorcontrib><title>Recombinant interferon drug targeting conservative HIV gp41 subunit membrane-proximal ectodomain and application thereof</title><description>The invention discloses a recombinant interferon drug targeting a conservative HIV (human immunodeficiency virus) gp41 subunit membrane-proximal ectodomain and application of the recombinant interferon drug. Comprising a 10E8 antibody or an antigen binding fragment thereof and a consensus interferon alpha, and the 10E8 antibody or the antigen binding fragment thereof is connected with the consensus interferon alpha through a linker. The antibody 10E8 capable of recognizing a highly conservative gp41 subunit MPER region of HIV outer membrane glycoprotein is used as a directional tool of the integrated interferon, a target spot exposed by an outer membrane protein allosteric structure of a virus in an infected cell can be accurately recognized, virus infection is prevented, a neutralization effect is achieved, and meanwhile, the antibody 10E8 can be used for identifying the high conservative gp41 subunit MPER region of the HIV outer membrane glycoprotein. The carried interferon molecules can be more effectively</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>TESTING</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjLEOgjAQQFkcjPoP5weQ2EBkNkSDi4MxruQoR21Cr017ED5fBj_A6S3vvW22PEl711lGFrAsFAeKnqGPkwHBaEgsG9CeE8UZxc4Ezf0NJpQK0tRNbAUcuS4iUx6iX6zDEUiL771Dy4DcA4YwWr3W61k-FMkP-2wz4Jjo8OMuO96ur7rJKfiWUkBNTNLWD6WqsjhV6nwp_nG-J_lG_Q</recordid><startdate>20240123</startdate><enddate>20240123</enddate><creator>JIAO CHANGLE</creator><creator>HU JIAQI</creator><creator>YUAN SHENGLING</creator><creator>DAI JINGJING</creator><creator>GUAN TONGTONG</creator><creator>HU XIANWEN</creator><creator>WEI YUANYUAN</creator><creator>ZUO MENG</creator><creator>LIU ZILONG</creator><creator>YUAN JIANJUN</creator><creator>ZHANG LIFANG</creator><creator>LIAO XIANG</creator><creator>LI LEI</creator><scope>EVB</scope></search><sort><creationdate>20240123</creationdate><title>Recombinant interferon drug targeting conservative HIV gp41 subunit membrane-proximal ectodomain and application thereof</title><author>JIAO CHANGLE ; HU JIAQI ; YUAN SHENGLING ; DAI JINGJING ; GUAN TONGTONG ; HU XIANWEN ; WEI YUANYUAN ; ZUO MENG ; LIU ZILONG ; YUAN JIANJUN ; ZHANG LIFANG ; LIAO XIANG ; LI LEI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN117430716A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2024</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>TESTING</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>JIAO CHANGLE</creatorcontrib><creatorcontrib>HU JIAQI</creatorcontrib><creatorcontrib>YUAN SHENGLING</creatorcontrib><creatorcontrib>DAI JINGJING</creatorcontrib><creatorcontrib>GUAN TONGTONG</creatorcontrib><creatorcontrib>HU XIANWEN</creatorcontrib><creatorcontrib>WEI YUANYUAN</creatorcontrib><creatorcontrib>ZUO MENG</creatorcontrib><creatorcontrib>LIU ZILONG</creatorcontrib><creatorcontrib>YUAN JIANJUN</creatorcontrib><creatorcontrib>ZHANG LIFANG</creatorcontrib><creatorcontrib>LIAO XIANG</creatorcontrib><creatorcontrib>LI LEI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JIAO CHANGLE</au><au>HU JIAQI</au><au>YUAN SHENGLING</au><au>DAI JINGJING</au><au>GUAN TONGTONG</au><au>HU XIANWEN</au><au>WEI YUANYUAN</au><au>ZUO MENG</au><au>LIU ZILONG</au><au>YUAN JIANJUN</au><au>ZHANG LIFANG</au><au>LIAO XIANG</au><au>LI LEI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Recombinant interferon drug targeting conservative HIV gp41 subunit membrane-proximal ectodomain and application thereof</title><date>2024-01-23</date><risdate>2024</risdate><abstract>The invention discloses a recombinant interferon drug targeting a conservative HIV (human immunodeficiency virus) gp41 subunit membrane-proximal ectodomain and application of the recombinant interferon drug. Comprising a 10E8 antibody or an antigen binding fragment thereof and a consensus interferon alpha, and the 10E8 antibody or the antigen binding fragment thereof is connected with the consensus interferon alpha through a linker. The antibody 10E8 capable of recognizing a highly conservative gp41 subunit MPER region of HIV outer membrane glycoprotein is used as a directional tool of the integrated interferon, a target spot exposed by an outer membrane protein allosteric structure of a virus in an infected cell can be accurately recognized, virus infection is prevented, a neutralization effect is achieved, and meanwhile, the antibody 10E8 can be used for identifying the high conservative gp41 subunit MPER region of the HIV outer membrane glycoprotein. The carried interferon molecules can be more effectively</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN117430716A
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
TESTING
VINEGAR
WINE
title Recombinant interferon drug targeting conservative HIV gp41 subunit membrane-proximal ectodomain and application thereof
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T11%3A38%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JIAO%20CHANGLE&rft.date=2024-01-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN117430716A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true